M. Pérol

机构：Centre Léon Bérard

发表论文 622 篇 · 总被引 20016 次 · h-index 59

代表论文

• Final Analysis Results and Patient-Reported Outcomes From DESTINY-Lung02—A Dose-Blinded, Randomized, Phase 2 Study of Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic NSCLC (2025 · Journal of Thoracic Oncology · 被引 22)
• Alectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: final overall survival analysis of the phase III ALEX study (2025 · Annals of Oncology · 被引 19)
• Trastuzumab Deruxtecan for ERBB2 -Mutant Metastatic Non–Small Cell Lung Cancer With or Without Brain Metastases (2025 · JAMA Network Open · 被引 15)
• Unresectable stage III non-small-cell lung cancer: state of the art and challenges (2025 · Nature Reviews Clinical Oncology · 被引 13)
• Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis (2025 · ESMO Open · 被引 9)
• ETOP 25-23 ADOPT-lung: An international, multicentre, open-label randomised phase III trial to evaluate the benefit of adding adjuvant durvalumab after neoadjuvant chemotherapy plus durvalumab in patients with stage IIB-IIIB (N2) resectable NSCLC (2025 · Lung Cancer · 被引 9)